These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 4551052

  • 1. Rheumatic disease sera reactive with capillaries in the mouse kidney.
    Tan EM, Pearson CM.
    Arthritis Rheum; 1972; 15(1):23-8. PubMed ID: 4551052
    [No Abstract] [Full Text] [Related]

  • 2. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
    Hanson V, Kornreich HK, Drexler E, Johnson GD, Macpherson GA.
    Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387
    [No Abstract] [Full Text] [Related]

  • 3. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS.
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract] [Full Text] [Related]

  • 4. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN, Joller-Jemelka HI, Grob PJ.
    Schweiz Med Wochenschr; 1974 Nov 09; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract] [Full Text] [Related]

  • 5. Patterns of nuclear fluorescence and DNA-binding activity.
    Luciano A, Rothfield NF.
    Ann Rheum Dis; 1973 Jul 09; 32(4):337-41. PubMed ID: 4580007
    [No Abstract] [Full Text] [Related]

  • 6. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B.
    Ann Rheum Dis; 1975 Apr 09; 34(2):197-8. PubMed ID: 1094966
    [No Abstract] [Full Text] [Related]

  • 7. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D, Rovenský J, Cebecauer L, Hajzok O.
    Fysiatr Revmatol Vestn; 1973 Jun 09; 51(3):152-7. PubMed ID: 4592583
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA, Beutner EH, Eisenberg RB.
    Int Arch Allergy Appl Immunol; 1973 Jun 09; 45(6):868-79. PubMed ID: 4586867
    [No Abstract] [Full Text] [Related]

  • 9. Urinary immunoglobulins in rheumatoid arthritis and other connective tissue diseases.
    Lindström FD.
    Ann Clin Res; 1971 Feb 09; 3(1):39-45. PubMed ID: 4100602
    [No Abstract] [Full Text] [Related]

  • 10. Immunofluorescent method for the detection of antigammaglobulin antibodies.
    Estes D, Atra E, Peltier A.
    Arthritis Rheum; 1973 Feb 09; 16(1):59-65. PubMed ID: 4571049
    [No Abstract] [Full Text] [Related]

  • 11. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD, Kurata N, Tan EM.
    Ann Intern Med; 1975 Oct 09; 83(4):464-9. PubMed ID: 1080976
    [Abstract] [Full Text] [Related]

  • 12. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N, Bosković B.
    Med Arh; 1985 Oct 09; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract] [Full Text] [Related]

  • 13. [Demonstration of antinuclear factors using the immunologic enzyme technic].
    Storch H.
    Z Gesamte Inn Med; 1973 Jan 15; 28(2):29-32. PubMed ID: 4120838
    [No Abstract] [Full Text] [Related]

  • 14. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C, Mejía Arreguín S, Orozco Medina JH, González Mendoza A.
    Rev Invest Clin; 1984 Jan 15; 36(2):115-9. PubMed ID: 6385174
    [No Abstract] [Full Text] [Related]

  • 15. The occurrence of immunoglobulins in the dermo-epidermal junction of the skin in lupus erythematosus and related syndromes.
    Kalsbeek GL, Cormane RH.
    Dermatologica; 1967 Jan 15; 135(2):205-15. PubMed ID: 4167752
    [No Abstract] [Full Text] [Related]

  • 16. Immunoglobulin G subclasses of antinuclear antibodies and renal deposits. Comparison of systemic lupus erythematosus, drug-induced lupus and rheumatoid arthritis.
    Kacaki JN, Callerame ML, Blomgren SE, Vaughan JH.
    Arthritis Rheum; 1971 Jan 15; 14(2):276-82. PubMed ID: 4927485
    [No Abstract] [Full Text] [Related]

  • 17. Immunoglobulin deposits in the dermo-epidermal junction zone in patients with systemic lupus erythematosus. Rheumatoid arthritis and temporal arteritis compared by serological testing including alpha2-macroglobulin.
    Permin H, Juhl F, Wiik A, Balslov JT.
    Scand J Rheumatol; 1977 Jan 15; 6(2):105-10. PubMed ID: 70840
    [Abstract] [Full Text] [Related]

  • 18. Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
    Cossio PM, Arana RM, Morteo OG, Hübscher O, Roux EB.
    Ann Rheum Dis; 1971 Nov 15; 30(6):640-4. PubMed ID: 5316115
    [No Abstract] [Full Text] [Related]

  • 19. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z.
    Acta Med Iugosl; 1970 Nov 15; 24(3):229-40. PubMed ID: 4928076
    [No Abstract] [Full Text] [Related]

  • 20. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S, Ritchie RF.
    J Immunol; 1974 Oct 15; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.